1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Leukapheresis Market – By Product Type

1.3.2        North America Leukapheresis Market – By Application

1.3.3        North America Leukapheresis Market – By End User

1.3.4        North America Leukapheresis Market – By Country

2.          North America Leukapheresis Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Leukapheresis Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.3        Expert Opinions

5.          North America Leukapheresis Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Surging Number of Voluntary Blood Donors

5.1.2        Raising Incidence of Hematologic Diseases

5.1.3        Up-lifting Elderly Population

5.2        Key Market Restraints

5.2.1        High Price of Leukapheresis

5.3        Key Market Opportunities

5.3.1        Growing Opportunities in Emerging Economies

5.4        Future Trends

5.4.1        Progress in Therapeutic Apheresis

5.5        Impact Analysis

6.          North America Leukapheresis – Market Analysis

6.1        North America Leukapheresis Market Revenue Forecast and Analysis

7.          North America Leukapheresis Market Analysis – by Product Type

7.1        Overview

7.2        North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3        Leukapheresis Devices

7.3.1        Overview

7.3.2        Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Apheresis Devices

7.3.2.1.1          Overview

7.3.2.1.2          Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1          Overview

7.3.2.2.2          Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Leukoreduction Filters

7.3.2.3.1          Overview

7.3.2.3.2          Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4        Leukapheresis Disposables

7.4.1        Overview

7.4.2        Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8.          North America Leukapheresis Market Analysis – by Application

8.1        Overview

8.2        North America Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3        Research Applications

8.3.1        Overview

8.3.2        Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4        Therapeutic Applications

8.4.1        Overview

8.4.2        Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9.          North America Leukapheresis Market Analysis – by End User

9.1        Overview

9.2        North America Leukapheresis Market Share by End User 2021 & 2028 (%)

9.3        Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4        Blood Component Providers and Blood Centers

9.4.1        Overview

9.4.2        Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5        Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6        Hospitals and Transfusion Centers

9.6.1        Overview

9.6.2        Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10.       North American Leukapheresis Market – Country Analysis

10.1      Overview

10.1.1     North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       Overview

10.1.1.1.2       US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.1.1.3.1     US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4       US: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5       US: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2       Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       Overview

10.1.1.2.2       Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3       Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)

10.1.1.2.3.1     Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.4       Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.5       Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3       Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       Overview

10.1.1.3.2       Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)

10.1.1.3.3.1     Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4       Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5       Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11.       North America Leukapheresis Market – Impact of COVID-19 Pandemic

11.1      Impact Assessment of COVID-19 Pandemic

12.       Leukapheresis Market– Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.       Company Profiles

13.1      Asahi Kasei Corporation

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Fresenius SE & Co. KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Haemonetics Corporation

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Terumo Corporation

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      STEMCELL Technologies Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      HemaCare

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Macopharma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      AllCells

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      STEMEXPRESS

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   BioIVT

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

Table 1.            US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 2.            US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3.            US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.            US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.            Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 6.            Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7.            Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.            Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.            Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)

Table 10.          Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11.          Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Leukapheresis Market

Figure 1.           North America Leukapheresis Market Segmentation

Figure 2.           North America Leukapheresis Market Segmentation, By country

Figure 3.           North America Leukapheresis Market Overview

Figure 4.           North America Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5.           The US to Show Significant Growth During Forecast Period

Figure 6.           North America Leukapheresis Market, Industry Landscape

Figure 7.           North America PEST Analysis

Figure 8.           North America Leukapheresis market impact analysis of driver and restraints

Figure 9.           North America Leukapheresis Market – Revenue Forecast and Analysis (2021-2028)

Figure 10.        North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11.        Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        North America Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17.        Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        North America Leukapheresis Market Share by End User 2021 & 2028 (%)

Figure 20.        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        North America: Leukapheresis Market, by Key Country – Revenue (2021 USD Million)

Figure 25.        North America: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26.        US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic in North American Country Markets